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ABSTRACT
Neuroendocrine (NE) cells use large dense core vesi-
cles (LDCVs) to traffic, process, store and secrete
neuropeptide hormones through the regulated secre-
tory pathway. The dimmed (DIMM) basic helix-loop-
helix transcription factor of Drosophila controls the
level of regulated secretory activity in NE cells. To
pursue its mechanisms, we have performed two in-
dependent genome-wide analyses of DIMM’s activi-
ties: (i) in vivo chromatin immunoprecipitation (ChIP)
to define genomic sites of DIMM occupancy and (ii)
deep sequencing of purified DIMM neurons to char-
acterize their transcriptional profile. By this com-
bined approach, we showed that DIMM binds to con-
served E-boxes in enhancers of 212 genes whose
expression is enriched in DIMM-expressing NE cells.
DIMM binds preferentially to certain E-boxes within
first introns of specific gene isoforms. Statistical ma-
chine learning revealed that flanking regions of puta-
tive DIMM binding sites contribute to its DNA binding
specificity. DIMM’s transcriptional repertoire features
at least 20 LDCV constituents. In addition, DIMM no-
tably targets the pro-secretory transcription factor,
creb-A, but significantly, DIMM does not target any
neuropeptide genes. DIMM therefore prescribes the
scale of secretory activity in NE neurons, by a sys-
tematic control of both proximal and distal points in
the regulated secretory pathway.
INTRODUCTION
In the mammalian hypothalamus, a small cohort of neu-
roendocrine (NE) neurons produces the peptide hormones
vasopressin (VP) or oxytocin (OX) for release into the blood
via the hypophysial portal system. Peptides like VP and OX
must travel long distances, in sufficient quantities and at the
appropriate times to deliver organism-critical physiological
information. Thus to perform their cellular functions, NE
neurons like the VP- and OX-expressing neurons must co-
ordinate and respond to a complex set of physiological, cel-
lular and biochemical requirements (1). They must produce
large amounts of secretory products and balance that de-
mand with a comparably high secretory capacity. Further-
more, they must place those secretory products in a readily
releasable storage compartment and then recognize and re-
spond to specific triggering stimuli, by releasing a large frac-
tion of the stored peptide in a short period of time. Finally,
that cycle of synthesis, storage and accurately timed release
must begin anew and proceed in phase with the previous
cycle of release.
These complex, high volume and highly choreographed
features of regulated protein secretion are not generalized
cellular properties. Instead, a series of molecular and ge-
netic studies in vitro and in vivo suggest that such cellular
properties result from sophisticated and cell-intrinsic ge-
netic programs (2,3,4). Several transcription factors play
instrumental roles in these programs, including: (i) XBP1
that promotes expansion of the rough endoplasmic retic-
ulum (ER), regulates the unfolded protein response and
may be required for differentiation of dedicated secretory
cells such as antibody-secreting plasma cells and intestinal
Paneth cells (5); (ii) REST that in PC12 cells governs a suite
of genes that coordinately support neurosecretion (6); and
(iii) the CREB-A protein that inDrosophila promotes a pro-
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secretory program in constitutively secreting tissues like the
salivary glands (7).
In Drosophila NE neurons, the basic helix-loop-helix
(bHLH) TF DIMM is an important component of this ge-
netic regulatory program. By virtue of its normal expres-
sion, and its loss-of-function phenotypes, we have proposed
that DIMM is required to support the dedicated, high se-
cretory capacity of NE neurons that produce many diverse
NE peptides (8,9,10,11). Its mammalian ortholog, Mist1, is
a comparable regulator of high secretory capacity in serous
(protein-secreting) exocrine cells (12,13). DIMMandMist1
are prototypical scaling factors (14): they specify the quan-
titative features of cellular phenotype, and not its qualitative
aspects (i.e. they are not cell fate determinants).
Neuropeptides and peptide hormones are processed and
stored within specialized large dense-core vesicles (LDCVs)
(15,16). DIMM is a pro-LDCV regulatory factor: when it
is mis-expressed in conventional (i.e. non-peptidergic) neu-
rons, it efficiently converts them to an NE function (17).
That transformation includes the dramatic downregulation
of synaptic active zones and of small synaptic vesicles, and
the remarkable promotion of functional LDCVs. DIMM-
dependent LDCVs are functional because they can store
ectopic neuropeptides and because they permit complete
post-translational precursor processing. The ability to pro-
mote biogenesis of complete sub-cellular organelles paral-
lels the actions of two notable transcriptional regulators.
First is the transcriptional coactivator PPAR coactivator-
1 alpha (PGC1), which promotes commitment of cellular
resources to adenosine triphosphate (ATP) production (18).
Its mis-expression in vivo leads to increased mitochondrial
mass in the heart at the expense of other organelles (19),
and it activates many key mitochondrial genes (20). Like-
wise, transcription factor EB (TFEB), a bHLH-leucine zip-
per TF promotes lysosomal biosynthesis, and directly reg-
ulates a network of ∼300 target genes that include numer-
ous structural components of the lysosome and other tar-
gets that protect against leakage of proteases from it. Thus
transcriptional regulation of entire sub-cellular organelles
by Scaling Factors, like PGC1 and TFEB, provides an ef-
ficient means by which cellular physiology can be compart-
mentalized and adapted to changing homeostatic demands.
Our research is directed at understanding the mecha-
nisms by which the DIMM Scaling Factor efficiently co-
ordinates the cellular machinery underlying regulated se-
cretory capacity and the production of specialized LDCVs
in NE cells. To pursue that goal, we previously identified
a total of ∼10 DIMM direct transcriptional targets us-
ing highly focused molecular screens (11,21). That list in-
cludes the neuropeptide biosynthetic enzyme Phm and the
cytochrome b-561 isoformCG1275. The latter is an integral
LDCV membrane protein that provides reducing equiva-
lents from the cytosol to the LDCV lumen to replenish
the stores of ascorbate (a necessary Peptidylglycine alpha-
amidating monooxygenase (PHM) cofactor that is oxidized
with each reaction cycle; (22)). To extend that analysis be-
yond the provisional list of just a few targets, we now re-
port on the use of two independent molecular methods that
together provide a genome-wide description of the DIMM
transcriptional program. The aims are 2-fold: to create a
molecular signature of DIMM binding sites and to provide
a broad definition of which genes DIMM targets. In doing
so, we sought to produce hypotheses that can describe the
scope of DIMM’s cellular activities.
MATERIALS AND METHODS
Chromatin immunoprecipitation-chip
We performed chromatin immunoprecipitation (ChIP) as
previously described (21,23). Briefly, tagged ChIP was car-
ried out with a DIMM::MYC-tag fusion transgene that can
rescue diminished neuropeptide levels in DIMM null ani-
mals (10). In order to express DIMM::MYC only in adult
DIMM-expressing neurons, we used the TARGET system
(24). The UAS-dimm::myc transgene was combined with
a temperature-sensitive tub-GAL80ts element and c929-
GAL4, which is inserted in a dimm enhancer and overlaps
almost completelywithDIMMprotein (8,10). Animals har-
boring all three elements and control animals lacking UAS-
DIMM::MYCdeveloped normally at the restrictive temper-
ature (18◦C), with undetectable DIMM::MYC expression
(data not shown). Two-to-three-day-old adults were shifted
to the permissive temperature (30◦C) and specific induction
of the DIMM::MYC protein within 72 h was confirmed by
western blotting (data not shown). Two sets of animals were
used for this experiment: (i) c929-GAL4/UAS-dimm::myc;
tub-GAL80ts/+ (experimental group) and (ii) c929-GAL4;
tub-GAL80ts maternal strain (negative control). Following
crosslink reversal, DNA was processed according to the
Affymetrix R© Chromatin Immunoprecipitation Assay Pro-
tocol (P/N 702238 Rev. 3). For each sample, 10 l of undi-
luted ChIP DNA or 1:10-diluted input DNA was amplified
by linear polymerase chain reaction (PCR)-based amplifi-
cation. We used quantitative PCR as described by Menet
et al. (23). To confirm that, even after amplification, DIMM
continued to occupy a known binding site in the target Phm
(11), 6 g of each amplified sample was fragmented and
biotin-labeled by Terminal Deoxynucleotidyl Transferase,
then hybridized to Affymetrix GeneChip R© Drosophila 2.0
Tiling Arrays and scanned according to Affymetrix proto-
cols at the National Center for Behavioral Genomics (Bran-
deis University).
Bioinformatics analysis of ChIP-chip data
To detect statistically significant DIMM binding peaks
throughout the genome we used the Model-based Analy-
sis of Tiling-arrays (MAT; (25)). The following settings were
used:MAT version 06022009 with BandWidth= 300,Max-
Gap = 300 and MinProbe = 8. The resulting MAT score,
which is calculated from normalized probe intensities, rep-
resents a statistical likelihood that a particular genomic re-
gion is enriched in the immunoprecipitated relative to the
control sample (26). A total of eight tiling arrays were used:
two independent biological replicates each, of:
(1) w;c929-GAL4/UAS-DIMM::MYC;
tubgal80ts/+ MYC ChIP;
(2) w;c929-GAL4/UAS-DIMM::MYC;
tubgal80ts/+input DNA;
(3) w;c929-GAL4; tubgal80tsMYC ChIP;
(4) w;c929-GAL4; tubgal80tsinput DNA.
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Thus, an identical number of arrays were used for exper-
imental and control samples, with the same number of bio-
logical replicates andDNA amounts hybridized to tiling ar-
rays. Analysis and normalization was carried out as follows:
samples from #1 were normalized against input in #2 in
MAT. Samples from#3were normalized against their input
in #4 inMAT. In order to provide additional stringency and
as a means of independent verification, ChIPed DNA from
experimental samples in #1 was normalized directly against
ChIPed DNA in controls in #3 in MAT. Next, raw signals
from MYC ChIP signal normalized to its input of the con-
trol sample (#3–#4) were subtracted from the experimental
group MYC ChIP signal normalized to its input (#1–#2).
Raw signal derived from normalizing MYC ChIP in the ex-
perimental group to MYC ChIP in the control group (#1–
#3) was then added to the subtracted signal (#1 – #2) – (#3
– #4). This is represented by the following equation: [(#1 –
#2) – (#3 – #4)] + (#1 – #3).We found that signal peaks ob-
tained from (#1 – #2) – (#3 – #4) normalization coincided
with peaks from (#1 – #3) normalization in majority of
cases. Therefore, we felt that obtaining binding peaks in the
same location defined by these two different normalization
steps enhanced the data fidelity. For example, the known in
vivoDIMM target Phm demonstrates a distinct signal peak
over its first intron that overlaps in the (#1 – #2) and (#1
– #3) normalizations, whereas (#3 – #4) showed no bind-
ing (see Supplementary Figure S3). Statistically significant
deviations of signal from baseline were calculated for this
twice normalized raw signal at P-value ≤1 × 10−4 with a
naı¨ve peak caller algorithm (Cistrome). Visual output from
all three MAT analyses performed (DIMM ChIP/Input,
NEG ChIP/Input and DIMM ChIP/NEG ChIP) can be
directly compared to each other as long as the windowmin-
ima and maxima are identical.
Genomic annotation of DIMM ChIP-chip peaks
We annotated DIMM binding sites with Galaxy and
Cistrome, using Flybase release 5.50 used for all anno-
tations (27,28). Figure 3B, C, D and F was produced
in the CEAS package (29). Figure 4F and G was pro-
duced in the SitePro package (29). Figure 6 was pro-
duced with the Heatmap tool (Cistrome) and GENE-
E (http://www.broadinstitute.org/cancer/software/GENE-
E/). All other graphs were produced in OS X R version
3.0.2 GUI 1.62 or in Microsoft Excel 2011. Cistrome Se-
qPos was used to detect statistically significant DNA bind-
ing motifs (28). Found motifs were confirmed with an in-
dependent analysis in RSAT (30). For conservation anal-
ysis, UCSC Genome Browser dm3 phastCons15way table
was used (31). We conducted ontology analysis in GO Elite
v1.2.6 (32), and results were visualized in Cytoscape v.3.0.2
(33). For LDCV constituent analysis, we used data from
Gauthier et al. (34), derived from a proteomic analysis of
the corticotropes dense-core secretory granules. Addition-
ally, we used a recently published list of human LDCV
constituents derived from proteomic analysis of a human
pheochromocytoma sample (35). Drosophila orthologs of
the human LDCV constituent genes were identified in Fly-
mine (36) and genetic interactions were mined fromFlybase
(37).
DNA sequence and shape analysis
DIMM binding sites were derived from the ChIP-chip
peaks and aligned based on their conserved E-box motifs,
CATATG or CAGCTG. DNA sequence features were de-
rived from the flanks of these core motifs. DNA shape fea-
tures (minor groove width, roll, propeller twist and helix
twist) were predicted using DNAshape, a high-throughput
method for inferringDNA shape parameters from sequence
(38). Models combining DNA sequence and shape features
were trained using L2-regularized multiple linear regres-
sion (MLR) with the assumption that ChIP-chip peaks in-
dicate bound DIMM sites (response variable assigned a
value of 1), whereas the random first-intron E-boxes rep-
resent unbound sites (response variable assigned a value of
0). The performance of sequence-based, shape-based and
sequence+shape classification models was evaluated using
area under the curve (AUC) values derived from the re-
ceiver operating characteristic (ROC) curves based on 10-
fold cross validation.
In vitro luciferase DIMM transactivation assays
We performed luciferase assays as described by Park et al.
(21), selecting DIMM-bound genomic fragments based on
their MAT scores, and in some cases based on their intronic
location. Assays were performed with at least n = 3 biolog-
ical replicates.
Preparation of cells for fluorescence-activated cell sorting
We harvested cells from brains of homozygous w1118, UAS-
dcr2; c929-GAL4, UAS-cD8::EGFP; flies for fluorescence-
activated cell sorting (FACS) and subsequent RNA-Seq.
This strain is essentially wild-type with respect to DIMM
physiology, as evidenced by normal neuropeptide staining
(data not shown). Young flies (5–12-days old) grown at
25◦C on standard Drosophila cornmeal media were anes-
thetized with carbon dioxide and collected on ice. We dis-
sected brains of 140 (first experiment) and 180 flies (sec-
ond experiment) within a 2–3-h time period in cold saline,
as in Nagoshi et al. (39) with some modifications. We used
sterile, ice-cold Modified Dissecting Saline (MDS) for dis-
sections (9.9-mMHEPES-KOHbuffer, 137-mMNaCl, 5.4-
mMKCl, 0.17-mMNaH2PO4, 0.22-mMKH2PO4, 33-mM
glucose, 43.8-mM sucrose, pH 7.4; (40)). Isolated brains
were immediately transferred into sterile, chilled modified
SMactive medium: they were pooled in a 2-ml Eppendorf
DNA LoBind nuclease-free tube, then washed with 1 ml of
chilled MDS (SMactive medium containing 5-mM Bis-Tris;
(41)).
Fly brains were then centrifuged at 1000 x g for 30 s in
a microcentrifuge. Frozen L-cysteine-activated papain (50
units/ml in dissecting saline; Worthington) was activated at
37◦C for 20 min immediately prior to the end of dissection.
We then added 450 l of activated papain to the brains,
resuspended them and then incubated with papain for 20
min at room temperature. Papain digestion was quenched
by adding 1.5 ml of Schneider’s medium supplemented with
1% heat-inactivated Fetal Calf Serum. The sample was cen-
trifuged at 500 x g for 30 s at room temperature. Brains were
washed two more times and were finally resuspended in 600
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l of Schneider’s medium supplemented with 1% Fetal Calf
Serum (FCS).
Papain-digested brains were then triturated 30 times with
a flame-rounded P1000 filter tip (medium tip opening), 30
times with a flame-rounded P1000 filter tip (small opening),
30 times with a flame-rounded P200 filter tip (large open-
ing), 40 times with a flame-rounded P200 filter tip (medium
tip opening) and 20 times with a flame-rounded P200 fil-
ter tip (small opening). Pipette volumes used for trituration
were 500 and 150l for the P1000 and P200 pipettes, respec-
tively. Trituration efficiency was moderate, such that very
small pieces of brain tissue were still visible under a dissec-
tion microscope at the end of the procedure.
We strained the brain homogenate through a sterile
70-micron cell strainer (Fisher Sci) mounted on a 50-
ml Falcon, then centrifuged briefly at 400 rpm at 4◦C.
Flow through containing filtered dissociated cells was then
strained through a 35-micron sterile cell strainer (BD Fal-
con) mounted on a 50-ml Falcon, then centrifuged briefly at
200 rpm. 450 l of dissociated single cells were collected in
a 6-ml BD Falcon tube and transported on ice to theWash-
ington University Siteman Flow Cytometry Core for FACS
sorting.
FACS sorting
Cell sorting was performed on a DAKO-Cytomation
MoFlo High Speed Sorter at the Siteman Flow Cytome-
try Core, Washington University in St. Louis. The green
fluorescent protein (GFP+) gate was set based on estab-
lished criteria and experience of the Core’s personnel with
the sorter. Sorting GFP+ and GFP− cells was completed
within 1 h of the start of sorting. Roughly, 1–3% of all
cells in the samples were GFP+, which is consistent with
the number of c929+ cells in the adult fly brain (42). In or-
der to establish the viability of cells after dissociation, a pi-
lot sorting experiment was performed in which cells were
sorted for GFP, as well as their ability to exclude the vi-
tality dye 7-Amino-Actinomycin D. This nucleic acid dye
allows detection of dying cells by entering such cells due
to fragmentation of their membranes (43). The pilot ex-
periment showed that the majority of gated GFP+ and
GFP− cells excluded 7-AAD, andwere therefore alive at the
time of sorting. The fact that sorted DIMM+ cells were vi-
able shortly before RNA capture increased confidence that
any subsequent expression profiling would faithfully repro-
duce the transcriptome of live DIMM+ cells. Because dou-
ble sorting against GFP and 7-AAD doubled the amount
of time needed for sorting, sorting experiments for RNA
collection were conducted without 7-AAD. The combined
number of cells sorted from the two experiments was 3.0 ×
105 GFP+ cells and 1.35 × 106 GFP− cells.
RNA isolation, processing and illumina HiSeq 2000 sequenc-
ing
At the end of sorting, cells were transferred directly
into Qiagen’s RLT buffer supplemented with beta-
mercaptoethanol (Qiagen RNA MinElute kit). Most
investigators harvesting nano scale RNA samples for
microarray gene expression profiling use the Arcturus
PicoPure kit (13,39). This kit contains a poly(dI:dC)-based
proprietary nucleic acid carrier embedded in the column.
This carrier does not interfere withmicroarray applications,
but could interfere with deep sequencing of RNAs isolated
this way. Therefore, we decided to use the Qiagen kit for
small samples, which lacks carriers. After transferring cells
into RLT buffer, they were vortexed for 6 s, and lysed
by passing the suspension five times through a 21.5 gage
needle mounted on a 3-ml syringe. RNA was isolated as
recommended by Qiagen’s MinElute protocol, with the
exception of using 65◦C-heated water for enhanced RNA
recovery. Next, DNA in the sample was digested with
the DNase I Turbo DNA-free kit (Ambion). After DNA
removal, RNAs isolated from GFP+ and GFP− cells from
each of the two experiments were pooled.
Samples with pooled GFP+ and GFP− RNAs were
then submitted to the Genome Technology Access Cen-
ter (Washington University Genetics Department). RNA
quality was then checked by Qubit (Invitrogen), NanoDrop
(GE Health) and Bioanalyzer (Agilent) quality control as-
says. Neither sample showed signs of degradation or DNA
contamination. Thirty-five nanograms ofRNA fromGFP+
cells left and 35 ng ofRNA fromGFP− cells were processed
for sequencing on Illumina’s HiSeq 2000 platform.
Because Illumina’s deep sequencing protocols require
10 g of RNA, the samples were amplified with the Nu-
GenOvation RNA-Seq system, a single primer-based RNA
amplification product that uses isothermal amplification
(44,45). After amplification, the samples were prepared for
deep sequencing according to standard Illumina proce-
dures, which included a poly-A selection step and multi-
plexing. Sequencing was performed in a single lane of an
Illumina HiSeq 2000 machine. Base calls were made by Il-
lumina’s software (Eland), followed by demultiplexing.
Cufflinks and Tophat algorithm were used to align raw
sequence reads to the reference genome and to map splice
junctions against Drosophila dm3 r5.50 genome release
(46,47). Alignments were indexed and sorted for visualiza-
tion in the IntegratedGenomicsViewer (48). IndexedRNA-
Seq reads were visualized as coverage tracks. In order to be
able to compare samples directly, coverage tracks were al-
ways graphed with identical y-axis coordinates.
ChIP-chip and RNA-Seq data integration
There were a total of 1809 ChIP-chip peak-associated tran-
scripts. 366 transcripts were not expressed in either se-
quenced sample. We applied a threshold to the data accord-
ing to absolute gene expression by searching for genes ex-
pressed at low levels, that are nevertheless known to be en-
riched in c929-GFP+ cells. The Pick1 gene (49) displayed
a transcriptional isoform expressed at 0.98 FPKMs in the
c929-GFP+ sample, and 0.26 FPKMs in the c929-GFP−
sample. It was the lowest expression level we could iden-
tify among genes previously identified by independent cri-
teria to be ‘c929-cell-enriched’. Therefore, we employed a
transcript expression cutoff of 0.98 FPKMs in the c929-
GFP+ sample throughout this study. In order to estab-
lish whether or not the statistical overlap was due solely to
chance, we calculated a cumulative hypergeometric proba-
bility as follows: population size = 30 459 total transcripts;
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Figure 1. Isolation of c929 (DIMM+) neurons from the adult brain. (A) Sample dissected adult brain used for sorting. (B) FACS-sorting of DIMM-positive
neurons (bottom right) and DIMM-negative randomly sorted neurons (bottom left) from dissected adult fly brains. (C) Light microscopy of control gate
cells lacking GFP expression (bottom) compared to high fluorescence gate cells (top). (D, D’) Electron micrographs depicting cells representative of ∼10
and ∼90%, respectively, of c929>GFP+ neurons after FACS and EM processing. (E) Electron micrograph showing a representative c929>GFP− neuron.
Figure 2. Deep sequencing ofDIMM+ cell and control cell transcriptomes reveals enrichment of known peptidergic markers and little overlap withmarkers
of major non-peptidergic neuronal subtypes. (A) The c929>GFP+ sample is highly enriched for dimm RNA (top). DIMM’s direct target Phm is ∼3.5-
fold enriched in the c929-GFP+ sample compared to the c929-GFP− sample. Likewise the known neurally-expressed bioactive peptides ilp2, ilp3 and Pdf
transcripts are all enriched in c929-GFP+ neurons, while the ilp1 and ilp4 transcripts (poorly expressed in the brain) are not detected in either transcriptome.
(B) Most, but not all, neuropeptide RNAs are strongly enriched in the c929-GFP+ cells compared to controls. This distribution compares favorably to
known neuropeptide distributions among DIMM+ neurons (52).(C) c929-GFP+ cells are not enriched for gene markers of GABAergic, dopaminergic,
cholinergic and glutamatergic neurons, compared to the c929-GFP− cell population.
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Figure 3. DIMM binds to more than 300 loci. In addition to binding known target genes such as Phm and CG1275, DIMM binds hundreds of novel
targets. (A) The schematic depicts genotypes and the experimental setup used for ChIP-chip. (B) DIMM binding is enriched near transcription start
sites and (C) depleted near transcription termination sites. (D) A ‘metagene’ profile derived from an average of all genes in the genome shows striking
enrichment of DIMM binding in the promoter/5′UTR sites, often peaking in the first 300 bp of a metagene. (E) ChIP-chip recapitulates known in vivo
DIMM binding to the first intron of Phm. Novel targets include Creb/ATF family pro-secretory transcription factors CrebA and cryptocephal, as well
as previously uncharacterized genes, such as CG4577. (F) DIMM binds preferentially to the first introns and transcriptional start sites, whereas DIMM
binding over remaining gene introns is depleted.
number of successes in population= 4105 transcripts simul-
taneously expressed at 0.98 FPKMs or higher in the c929-
GFP+ sample and enriched at 1.5-fold or higher in the c929-
GFP+ sample compared to the c929-GFP− sample; sam-
ple size = 1809 ChIP-chip associated transcripts; number
of successes in the sample = 337 ChIP-chip transcripts si-
multaneously expressed at the level of Pick1 or higher in
the c929-GFP+ sample and enriched at 1.5-fold or higher
in the c929-GFP+ sample compared to the c929-GFP−
sample. Instead of a simple hypergeometric probability, the
more stringent cumulative probability of obtaining 337 or
more hits due to chance alone was calculated: P(X ≥ 337)
was equal to 9.435933 × 10−11. Three hundred and thirty
seven ChIP-chip associated transcripts enriched at 1.5-fold
or higher with expression level greater or matching that of
Pick1 in the c929-GFP+ sample yielded a total of 212 genes.
RESULTS
The transcriptome of DIMM+ NE cells
We targeted c929-GAL4+ (c929+) neurons for purification
by directing their expression of GFP (genotype – w−,UAS-
dcr2; c929-GAL4,UAS-EGFP). Figure 1A illustrates GFP
expression in the brain of that genotype. Approximately 300
neurons (of a total of ∼50 000 neurons) are GFP+ (10).
Flies were dissected quickly en masse, and brains gently dis-
sociated by mild protease treatment (following the meth-
ods of Nagoshi et al. (39), with minor modifications––see
the Materials andMethods section). Vital dye staining pro-
duced no evidence for dying cells among dissociated cells
(data not shown); cells were then FACS-sorted to purify
DIMM-expressing, GFP+ cells away from all GFP− (non-
DIMM) cells (Figure 1B). Inspection of purified cell popu-
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Figure 4. DIMM binds to conserved E-boxes located close to the centers of DIMM ChIP-chip binding peaks. (A, B) DIMM preferentially binds to two
palindromic E-boxes, CATATG and CAGCTG. Both E-boxes match precisely known DIMME-boxes in the Phm 1st intron enhancer (21) ; the CATATG
E-boxmatches the SELEX-predictedDIMM-binding E-box (63). (C) Strand-specific conservation of the CATATGE-box in intronicDIMMbinding peaks
compared to∼800 randomly selected intronicCATATGE-boxes. (D) Strand-specific conservation of theCAGCTGE-box in intronicDIMMbinding peaks
compared to ∼800 randomly selected intronic CAGCTG E-boxes. (E) The CATATG E-box shows an enrichment for the CCATATG variant, particularly
around the centers of binding peaks. (F) The CATATG E-box is enriched in the center of DIMM-bound peaks (red) and lacks enrichment in CLOCK-
bound peaks (blue). CLOCK data from (26). (G) Multiple CATATG and CAGCTG E-boxes are seen dispersed throughout peak length, but they appear
concentrated near the center of DIMM-bound peaks. (H) DIMM-occupied genomic regions are GC-rich, particularly near the centers.
lations at the light level indicated that most/all of the c929-
GFP+ sample had green fluorescence, whereas the c929-
GFP− sample lacked such (Figure 1C). We predicted that,
if this purification method were efficient in capturing intact
DIMM+ cells, at least some c929-GFP+ cells should display
LDCVs in their cytoplasm. After FACS isolation, we there-
fore processed pools of GFP+ and GFP− cells for trans-
mission EM and studied >100 cells in each sample (Figure
1D and E). In spite of the extended dissection and dissocia-
tion procedure, a substantial fraction (∼10%) of individual
c929-GFP+ cells contained unambiguous LDCVs in their
cytoplasm, indicative of a normal NE differentiation (Fig-
ure 1D). We found no incidence of LDCV inclusion in the
c929-GFP− sample (Figure 1E).
We next defined the transcriptional profiles of the two
cell samples by deep sequencing with minimal amplification
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Figure 5. Receiver operating characteristic (ROC) curve of different mod-
els for classification of DIMM bound versus unbound putative sites based
onDNA sequence and shape features derived from the binding site’s flank-
ing regions. Area under the curve (AUC) values were calculated from
true positive rates plotted against false positive rates for classification of
bound versus unbound sequences containing the CATATG E-box. Dif-
ferent models, including a nucleotide sequence model (red), a DNA shape
model (combiningminor groove width, roll, propeller twist and helix twist;
blue), a shape-augmented sequence model (using both sequence and the
four DNA shape features; green) and a sequence-based model augmented
by only minor groove width (MGW; magenta), were used to distinguish
between bound and unbound DIMM target sites. The AUC values for the
CATATG E-box are given in the legend, and the respective values for the
CAGCTG E-box were 0.5980, 0.5921, 0.5941 and 0.5999.
(Supplementary Table S1). Those results confirmed earlier
suggestions of accurate sorting and high purity between
the two samples: the c929-GFP+ sample displayed high lev-
els of dimm transcription and the c929-GFP− sample dis-
played little to none (Figure 2A). Figure 2A also shows
RNA-seq tracks from Phm and several other well-defined
‘peptidergic’ loci. Phm is the amidating enzyme necessary
for neuropeptide biosynthesis for >90% of all Drosophila
neuropeptides (50), and a ‘bona fide’ direct DIMM target
(21). Phm is expressed in neurons throughout the CNS, at
low, medium and high levels––its highest levels are found
in DIMM+ NE cells (51). We obtained RNA-Seq data at
the Phm locus indicating a >4-fold enrichment of Phm in
DIMM+ cells versus that in randomly sorted cells (Figure
2A). Therefore, as predicted, Phm expression was enriched
in the c929-GFP+ sample, though it was not exclusive to
that cell type.
Different c929+ cells express diverse neuropeptides, all
at high levels (11). RNA-seq results were concordant with
those and similar histologic findings from earlier studies,
as the c929+ cell transcriptome was highly enriched for dif-
ferent neuropeptide RNAs (Figure 2B). For example, most
or all of the NE cells that express Pigment dispersing factor
(Pdf), eclosion hormone (Eh) and IFamide are DIMM+: the
c929-GFP+ cells likewise demonstrated a high degree of en-
richment of Pdf, Eh and IFa by RNA-Seq (Figure 2A and
B). In contrast, the two identified prothoracicotropic hor-
mone (PTTH) neurons are DIMM−, (neuropeptide) proc-
tolin neurons are largely DIMM− and most tachykinin-
expressing (Tk+) neurons are local interneurons and not
DIMM+ NE cells (52). Likewise, c929+ neuronswere poorly
enriched for these transcripts by RNA-Seq (Figure 2B bot-
tom). RNA-Seq specificity was further evident when ex-
amining the Drosophila insulin-like peptides Ilp2, Ilp3 and
Ilp5: they are expressed at high levels in the DIMM+ cells
of the Pars intercerebralis (52), a brain region sometimes
analogized with the mammalian hypothalamus (53). Other
Drosophila insulin genes, such as Ilp1 and Ilp4 are not ex-
pressed in the CNS at all (reviewed by Na¨ssel et al. (54)).
Figure 2A shows the Ilp1-4 locus, with clear enrichment of
Ilp2 and 3, whereas Ilp1 and Ilp4 are not enriched by RNA-
Seq. Thus, by a variety ofmeasures, the purified c929-GFP+
cell population displayed expected enrichment formany dif-
ferent transcripts predicted from previous diverse studies.
We also wanted to compare c929-GFP+ cells against pre-
viously characterized Drosophila neuronal cell subpopula-
tions. Figure 2C shows that c929-GFP+ cells express lower
levels of the GABAergic marker Gad1, the serotonergic
marker Ddc, the cholinergic marker VAchT and the gluta-
matergic markerVGlut compared to randomly sorted c929-
GFP− cells. These findings demonstrate that c929+ cells are
transcriptionally distinct from other neuronal subpopula-
tions known to engage predominantly in conventional (i.e.
non-peptidergic) neurotransmission.
We also compared the RNA-Seq results of the c929+
population with those from other purifiedDrosophila adult
brain cells, including Kenyon cells, Octopaminergic cells
and a generic neuronal population (elav+) (Figure 6A and
Supplementary Figure S1; (55)). Notably, many of the genes
that critically support neuropeptide biosynthesis (amon
(PC2), svr (CPD/E) and Phm) are all enriched in c929+
neurons, though not exclusively. For example, mRNA lev-
els of key NE proteins like the PC2-associated 7B2, the cy-
tochrome b-561 CG1275 and the copper transporter ATP-7
also display relative high levels in purified octopaminergic
cells (Supplementary Figure S1).
Genome-wide identification of direct DIMM targets by in
vivo ChIP-chip
To pursue the specific bases of DIMM actions, we next
turned to identify and quantify precise sites of DIMM
occupancy in vivo throughout the genome. For this pur-
pose, we employed a tagged ChIP-chip strategy ((26); see
the Materials and Methods section). We directed condi-
tional (i.e. adult-specific) expression of a UAS-dimm::myc
fusion transgene in adult c929+ neurons, but only after
flies had completed normal larval, pupal and adult devel-
opment stages (Figure 3A). We compared that genotype
to flies of identical genetic constitution, but lacking the
dimm::myc transgene (Figure 3A). We used a MYC anti-
body directed against the human MYC hexapeptide tag to
detect loci occupied by DIMM::MYC. For each sample,
anti-MYC ChIPs were carried out in parallel on both geno-
types. We normalized ChIP DNA against input DNA and
hybridized four samples per biological replicate, in parallel,
to Drosophila Affymetrix Tiling 2.0 arrays.
After normalization and averaging, we identified 384 ge-
nomic loci that boundDIMMat statistically significant lev-
els (P-value ≤1E-04; see the Materials and Methods sec-
tion) in two independent DIMM ChIP experiments. De-
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Figure 6. DIMM-binding sites correlate with expression of structural and functional elements of the regulated secretory pathway. (A) DIMM binds to
a core set of genes encoding biosynthetic, neuropeptide processing enzymes that are highly expressed by c929-DIMM+ cells. Gene expression from this
study compared to RNA-Seq data from (55) obtained from purified nuclei of octopaminergic and Kenyon neurons adult brain neurons. (B) Intersection of
ChIP-chip identified DIMM target genes and the c929-DIMM+ cell transcriptome. (C) DIMM does not bind to the defined neuropeptide-encoding genes
of the Drosophila genome.
scriptions of the loci are provided in Supplementary Table
S2. To evaluate the success of the tagged ChIP approach,
we examinedDIMMoccupancy at its known binding site in
the first intron ofPhm (Figure 3E; (11)): indeed, this site dis-
played statistically significant DIMMbinding. To begin the
process of identifying additional putative targets, genome-
wide, we next assigned annotated genes to each of the 384
DIMM-occupied peaks (see the Materials and Methods
section for details). Thus, we could map 384 peaks to 539
genes, albeit with some redundancy, reflecting those cases
when adjacent genes overlapped a single peak, and allow-
ing for some peaks that were not situated within 3 kb of an
annotated open reading frame. We used the modENCODE
classification of chromatin states (identified in the neuronal
BG3 cell line; modENCODE consortium (56)) to determine
that the majority of DIMM binding sites fell within areas
of active chromatin (Supplementary Figure S4).
DIMM binding was found at genes that represent (i)
knownDIMM targets such asPhm,CG1275 andmael (Fig-
ure 3E): these three were first identified in an embryonic
DIMMover-expression screen––Park et al. (21)); (ii) targets
with clear association with DIMM actions, though not pre-
viously defined as DIMM targets, i.e. neuropeptide biosyn-
thetic enzymes, such as PC2 (amon––(57)) and carboxypep-
tidase D/E (svr––(58)); as well as (iii) many others genes
whose actions can be inferred or remain unknown. We fur-
ther characterize and provide an overview ofDIMM targets
below.
Regarding the positions of DIMM binding sites at their
target genes, ChIP-chip signals were strikingly enriched
near transcription start sites and depleted near transcrip-
tion termination sites (Figure 3B and C). An analysis that
standardized the entire genome to a meta-gene structure
showed that these ChIP-chip signals peaked shortly fol-
lowing transcription start sites (Figure 3D). In particular,
DIMMbound preferentially to first introns and not to other
gene introns (Figure 3F).
DIMM binds to conserved CATATG and CAGCTG E-boxes
with high specificity
After determining that ChIP-chip data corroborated bind-
ing to the previously identified DIMM enhancer in Phm,
we next queried bound sequences for binding sites in an
unbiased manner. A motif-calling algorithm identified the
CCATATGG motif as the statistically most enriched mo-
tif (Figure 4A), with the AACAGCTGTT motif scor-
ing the second highest (Figure 4B). Of the 384 peaks,
271 contained at least one ‘so-called’ ‘TA’ or ‘GC’ E-box
(where TA or GC specifies the two central nucleotides
of the canonical CANNTG E-box); 162 of the 271 con-
tained more than one such E-box (Supplementary Table
S3). Evolutionary sequence conservation frequently corre-
lates with function: we therefore investigated the degree of
conservation of DIMM-bound E-boxes. Compared to E-
box sequences chosen from introns of other, ‘random’ eu-
chromatic genes, DIMM-bound CATATG and CAGCTG
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E-boxes were more conserved (Figure 4C and D). The
CATATG E-box was present at half the frequency of the
CAGCTGE-box in the fly genome, and appeared to be con-
served less, overall. Interestingly, DIMM-bound CATATG
E-boxes were quite conserved, and their overall number
nearly matched that of CAGCTG E-boxes in DIMM-
bound peaks. Furthermore, when the CATATG E-box is
examined, DIMM binding peaks showed a higher fre-
quency of CCATATG in their centers compared to other
nucleotides (ACATATG,GCATATG andCCATATG; Fig-
ure 4E), consistent with our previous findings (11). Indi-
vidual CATATG and CAGCTG E-boxes were represented
multiple times along the length of DIMM-binding regions
(Figure 4F and G). We compared DIMM binding to that
of CLOCK, a bHLH TF that binds predominantly to the
CACGTG E-box (Figure 4F––‘mapped 500’ data fromAb-
bruzzi et al. (26)): >90% of DIMM binding sites did not
overlap. This general feature of DIMM genomic targets
likely corresponds to the finding of multiple functional E-
boxes present in the DIMM-sensitive enhancer of Phm In-
tron 1 (11). Finally, we note that DIMM-binding sites are
enriched in GC-rich sequences, especially near their centers
(Figure 4G). Based on the computational analysis of the
putative DIMM-binding E-box, we conclude that DIMM
prefers to recognize and bind CATATG and CAGCTG in a
highly conserved manner.
DNA sequence and shape analysis reveals that DIMM bind-
ing site flanks contribute to its binding specificity
Increasing evidence suggests that the genomic context of
putative binding sites affects in vivo TF-DNA binding
(59). We therefore studied the effects of regions flanking
the core binding sites on the DNA binding preference
of DIMM aiming to explain why only a small subset of
putative binding sites is actually bound in vivo. Specifi-
cally, we constructed classification models, based on L2-
regularized MLR, that distinguish between bound and un-
bound DIMM binding sites. We assigned the random first-
intron E-boxes (as described above) as unbound sites and
E-boxes within ChIP-chip peak regions as bound sites.
Whereas the E-box cores of these two groups of target
sites were identical in their sequence composition, predic-
tive models that used features derived from flanks of the E-
box cores performed better in distinguishing bound from
unbound binding sites than a random classification. The
model performance was evaluated based on the ROC curve
and the calculated AUC. An AUC value of 0.5 indicates
a random classifier. For the two types of E-boxes with ei-
ther the CATATG or CAGCTG core, we compared differ-
ent models with the goal to identify features that distinguish
bound from unbound putative DIMM target sites. These
features included DNA sequence and shape features (mi-
nor groove width, roll, propeller twist and helix twist), as it
was previously shown for bHLH TFs that DNA shape ex-
erts the effect of the genomic flanks on binding specificity
(60). The AUC values for the four models based on nu-
cleotide sequence, four shape features, sequence augmented
with four shape features and sequence augmented with mi-
nor groove width suggested a better classification for the
CATACG E-box compared to the CAGCTG E-box (Fig-
ure 5). Whereas none of the features could be identified as
predominant, taken together, our results show that intrinsic
DNA sequence and shape signals encoded in the genomic
contexts, such as the flanks, of DIMM binding sites par-
tially explain its in vivo DNA binding specificity.
DIMM can transactivate many of its potential targets
Based on previous evidence, DIMM likely functions as a
transcriptional activator (11,21). To support that supposi-
tion, we used the BG3 Drosophila neuronal cell line and de-
termined if DIMM could transactivate a large number of
ChIP-chip-identified regulatory fragments from candidate
gene targets. We tested 16 of the 384 DIMM-bound regions
in luciferase transactivation assays (Supplementary Figure
S2). DIMM transactivated 12 of the 16 candidate regula-
tory fragments to significant levels. Interestingly, many of
the tested enhancers produced inductions that were many
fold higher than the strongest inductions recorded previ-
ously for target genes Phm, mael and CG6522 (21).
A high-confidence list of DIMM targets
Having performed two independent assessments of gene
expression in c929+ cells (ChIP-chip and RNA-Seq), we
wished to assess the overlap in gene lists so as to define a
high-confidence list of DIMM targets. Here we describe the
basis for creating the overlap. As shown in Table 1, ChIP-
chip produced 1809 transcripts of interest: these were de-
rived from 539 annotated genes that were adjacent to 384
DIMM-bound genomic loci. FromRNA-Seq, we identified
4105 transcripts: these were selected based on two proper-
ties. First they represented transcripts enriched >1.5-fold
in c929+ over c929− cell transcriptomes. Secondly, their
level of expression exceeded 0.983129 FPKM (Fragments
per kilobase of transcript per million mapped reads), which
is the level of expression in c929+ cells of the gene Pick1.
Pick1 levels were chosen as a threshold because they dis-
played the lowest level of expression for any gene known
to be enriched in c929/DIMM+ neurons (49). Comparison
of the two groups of transcripts reveals an overlap of 337
isoforms, which translates finally into 212 distinct DIMM
target genes (Figure 6B and Supplementary Tables S4 and
S5). It is noteworthy that no neuropeptide-encoding genes
are on the list due to the lack ofDIMMbinding (Figure 6C).
To provide a context to interpret the targets identified, we
categorize them into sets defined by GO functions (Supple-
mentary Table S6). The top three categories include synapse
assembly, peptide metabolic process and transport vesicle,
which are all terms generally consistent with the concerted
actions of DIMM to promote LDCV accumulation.
DISCUSSION
DIMMcan orchestrate an active and efficientRegulated Se-
cretory Pathway in NE neurons ofDrosophila. To deconvo-
lute these processes, we have obtained a broad set of high-
confidence DIMM targets. These results identify individ-
ual target gene candidates, some of which may explain how
DIMM carries out its gene regulation roles. Here we evalu-
ate the quality of the target list and preview ways in which
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Table 1. Overview of experimental results
this information can be used to better understand the pro-
gram of DIMM regulation and the cellular differentiation
of Neuroendocrine Neurons.
Evaluating the quality of the data set
Defining the genome-wide molecular targets for a single TF
is subject to both false-negative and false-positive entries.
In our studies, false negatives could arise due to the partic-
ular developmental stage studied or due to the possibility
that DIMM enhancers act at long distance. First we em-
phasize that the RNA-Seq results argue strongly against a
prevalence of false negatives: dimm expression was decid-
edly strong in the c929+ population, and essentially non-
existent in the c929− population. Nevertheless, false nega-
tives are an issue because several, previously defined, ‘bona
fide’ DIMM targets (like CG13248 and CG17293––(21))
did not appear in the final list of 212 gene targets. The ef-
fect of developmental stage is likely significant because the
current work was performed on adult tissues, whereas pre-
vious efforts were centered on pre-adult stages (11,21). To
explain that difference, we propose that some targets may
require early, phasic DIMM transactivation, while others
may require more sustained activation. Secondly, the effects
of long distance enhancers may also contribute to lessening
the percentage of true DIMM targets identified here, as we
selected candidate genes whose proximal endpoint was less
than 3 kb from significant DIMMbinding peaks. Inasmuch
as DIMM binds to numerous enhancers located within first
introns, we are confident that at least a large number of tar-
gets were correctly identified, thus minimizing the number
of false negatives.
Regarding possible false positives, we consider three
sources asmost likely: (i) contamination of the two cell pop-
ulations during sorting, (ii) mis-calling of adjacent genes
due to their overlap around a single DIMM binding site or
(iii) the use of DIMM over-expression in our experimen-
tal design. First, regarding the degree of cell sorting pu-
rity, we incorporated ultrastructural analysis of dissociated,
FACS-sorted neurons to provide electron microscopic ev-
idence that at least some NE neurons within the popula-
tion were structurally intact. The percentage of cells dis-
playing LDCV was low, but given the challenging treat-
ment by which cells were purified, and the resulting tran-
scriptional profiling, we submit cell health was not com-
promised. Second, as we described in Figure 2, predictions
of which neuropeptide transcripts should be enriched, and
which should not, based on a high degree of cell sorting
purity, were strongly supported. Thus we submit that cell
mis-sorting provided at most a minor degree of contam-
ination. However, the possibility that we mis-called tar-
get genes because they were adjacent to DIMM binding
sites, and were also coincidentally enriched in c929+ cells,
is more difficult to exclude. Future experiments must take
this possibility into consideration as individual targets are
evaluated. Finally, the risk that identified DIMM binding
sites may lack fidelity, due to use of a tagged DIMM over-
expression strategy, is a potential concern. We note that
Yao et al. (61) explicitly compared endogenous and over-
expressed MyoD binding sites: they concluded that over-
expression of an epitope-tagged MyoD did not alter the
profile of normal binding sites. Together these considera-
tions provide confidence that the resulting data set warrants
further in-depth interrogation to define the genome-wide
program of DIMM’s direct molecular actions.
The DIMM binding site
Previouswork demonstrated thatDIMMtransactivated the
amidating enzyme Phm by binding to specific E-boxes in
its first intron (11). That enhancer harbors several con-
served CATATG and CAGCTG E-boxes, three of which
(a single–TA- and two –GC-E-boxes) have been shown to
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be necessary and sufficient in vitro and in vivo for DIMM
transcriptional control (11). Similarly, the DIMM mam-
malian ortholog (called Mist1) binds to CATATG E-boxes
located in the first intron of six of its targets (62). Inter-
estingly, the experimentally identified CCATATGG mo-
tif corresponded to the DIMM binding motif discovered
by a high throughput bacterial one-hybrid assay (FlyFac-
torSurvey; (63)): http://pgfe.umassmed.edu/ffs/TFdetails.
php?FlybaseID=FBgn0023091). Therefore, the ChIP-chip-
identifiedDIMM-binding E-boxes, derived from analysis of
384 genomic fragments bound by DIMM in vivo, matched
previously identified E-boxes that DIMM binds to in order
to transactivate its targets. This finding increases confidence
in the significance of other sites that share these E-box sig-
natures.
Mechanisms used byDIMM to recognize in vivo binding sites
Besides established factors that contribute to TF binding
such as chromatin accessibility, methylation state, cofac-
tors and cooperative binding (64), DNA shape was recently
shown to exert the influence of genomic sequences that flank
TF binding sites on in vivo binding (59). Consistent with
that hypothesis, our results indicate that DNA shape in
flanking regions contributes as much as DNA sequence to
DIMM binding. The precise shape features that contribute
to the DIMM binding site remain unclear because classifi-
cationmodels using nucleotide sequence orDNA shape fea-
tures performed about equally well in distinguishing bound
and unbound target sites. Reasons for the inability to iden-
tify any predominant feature could be the limited sample
size of a few hundred sequences. Whereas adding shape to
sequence slightly improved the performance of the classifi-
cation model (Figure 5), the additional features could po-
tentially lead to overfitting, which counters a performance
increase due to additional information contained in DNA
shape features. This hypothesis is supported by the fact that
a model that only adds one shape feature, in this case minor
groove width (Figure 5), outperformed the sequence+shape
model, which uses four different shape features. While more
work is needed to identify these precise features, our re-
sults indicated thatDNAsequence or shape features derived
from the E-box flanking sequences play a role in controlling
DIMM binding.
The DIMM gene program
To begin discussing the DIMM program of gene activa-
tion we first note that a recently published account of a
gene expression screen yielded tens of genes that displayed
enriched expression in at least subsets of DIMM/PHM-
expressing Drosophila neurons (65). Interestingly, five of
these genes are also entries on our list of high-confidence
DIMM targets: ERp60, Pfrx, PI3-dependent kinase, hipk
and the RNA-binding protein alan shepard. Clearly the
DIMM gene program does not feature a simple linear logic
whereby a single critical activator is brought to bear. In-
stead, the present results indicate that DIMM instigates a
coordinated program of cellular activities, which we pro-
pose are divisible into functional categories.
LDCV components. Gene targets that represent LDCV
membrane constituents, or which help traffic and accumu-
late LDCV, are particularly interesting because of DIMM’s
ability to promote accumulation of LDCVwhen it is ectopi-
cally expressed (17). We submit therefore that the most sig-
nificant set of DIMM targets is the group of genes encod-
ing LDCV components. First we note five suspected LDCV
proteins on our high-confidence target list: ATP7, Cyt-b561
(CG1275), CSP and betaTUB56D. ATP7 is a dedicated
copper transporter, enriched in NE neurons (66) and crit-
ically important for the amidating enzyme PHM, which is a
DIMM target and which requires copper as a cofactor (22).
CSP is Cysteine String protein, which has been implicated
in regulation of the exocytotic event in themembrane fusion
of secretory granules (known for its role in regulated exocy-
tosis) (67). We already showed that CSP is upregulated in
vivo by ectopic DIMM (17) and so its candidacy as a direct
DIMM target is validated here. The Jaguar (JAR) protein is
an isoform of myosin VI (68), a myosin class that has been
implicated in secretory granule exocytosis (69). Along with
betaTUB56D, JAR may represent a critical component to
permit tethering and accumulation of LDCV in the endings
of NE neurons (cf. (70)).
Extensive proteomics analysis has identified hundreds of
proteins resident on human LDCV (35). Gauthier et al. (34)
identified ∼160 proteins on corticotroph dense core gran-
ules, 13 of which remarkably are also found on our list of
212 high value DIMM targets––Phm, Pal1, Pal2, amon,
seryl aminoacyl-tRNA synthase 1, EIfalpha48D (elonga-
tion Factor Tu), Pfrx, Pgk, chic (Profilin), eIF-4a, RpS16,
RpS2, capt (adenylate cyclase associated protein1). Two ad-
ditional DIMM targets are highly related (though not the
most highly related Drosophila genes) to the corticotroph
LDCV proteins prolyl-4-hydrolase (ERp60) and a dynein
light chain (ctp, though it is not in the ‘roadblock’ family
of dynein light chains). Thus more than 10% of the DIMM
targets here identified are likely components of LDCV as
schematized in Figure 7C. These findings argue strongly
that the primarymechanism of DIMMaction is to promote
organization of a stoichiometrically correct and functional
secretory granule.
Transcription. There are at least 14 TFs included, and sev-
eral of these also reveal a bias for pro-secretory functions.
Notably, CREB-A, a bZIP TF that is especially important
as a master regulator of secretory functions in a variety of
cell types is a prominent DIMM target. In salivary gland,
Andrews et al. have shown that CREB-A is a critical co-
ordinating factor in the normal dedication of secretory ca-
pacity (7,71), and is a member of the CREB3 family, which
appears to have a general role in regulating secretory ca-
pacity (72). We interpret the inclusion of CREB-A in the
DIMM target list to indicate the co-opting of this secre-
tory program regulator by DIMM to confer its program of
high capacity secretory function onto NE cells. DIMM up-
regulates several other bZIP TFs including ATF-4 (crypto-
cephal), and vrille and a few bHLH proteins on the list in-
cluding HLH4C, sima and the orange-domain containing
cwo (clockwork orange). Several of these have previously
been implicated in control of ER capacity in high-level se-
cretory cell types (9,73,74). Finally, we note the transcrip-
 at W
ashington U
niversity, Law
 School Library on July 6, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015, Vol. 43, No. 4 2211
Figure 7. Schematic overview of the DIMM transcriptional output responsible for orchestration of the RSP inNE cells. Illustration of a small conventional
neuron (bottom) next to a larger DIMM+ NE cell. Various DIMM targets are selected to feature the proximate and distal levels of the secretory pathway
that DIMM supports––including nuclear factors that govern specific gene expression, RNA-binding proteins that govern specific translation, Golgi-related
factors that regulate the secretory process and LDCV components (in the expanded box).
tion factor HR4 helps shape responsiveness to ecdysteroid
pulses (75), which could be a useful feature for NE neu-
rons as they must coordinate their activities closely with the
endocrine system that controls developmental timing in in-
sects (e.g. Inka cell physiology).
Neuropeptide biosynthesis. Based on many previous re-
sults concerning DIMM regulation of Phm, it was ex-
pected that DIMM should directly target several additional
neuropeptide biosynthetic enzymes. The present results
strongly confirm this general hypothesis. These enzymes
are LDCV proteins (both luminal and membrane compo-
nents) that help process neuropeptide precursors transiting
through the trans-Golgi to specific secretory granules (22).
DIMM targets many of the genes that encode major en-
zymes in this pathway, including Phm (50), Pal1 and Pal2
(76), amon (dPC2; (57)) and silver (CPD; (58)). Some of
theseDrosophila genes encode multiple isoforms, only some
of which operate in the context of neuropeptide biosynthe-
sis. For example, silver produces several different RNA iso-
forms from different promoters that serve both neural and
non-neural functions and which have different sub-cellular
localizations (77). DIMM transactivates svr via the first in-
tron of a specific short isoform whose transcript is enriched
in c929+ neurons. Another putative neuropeptide biosyn-
thetic enzyme targeted by DIMM is the GC––gamma car-
boxylase (78)). To date, no Drosophila neuropeptides have
been identified with a gamma-carboxylate modification.
Secretory pathway. The DIMM target list contains nu-
merous factors involved in theRegulated Secretory Pathway
and more specifically, in LDCV biogenesis: these include
ARF6-GEF schizo, atl, Arf79F (the Drosophila Arf1/2/6
ortholog), RhoGEF3 and RanGAP. Of special note in this
context is the target Rab2: it represents a critical point of
regulation in the transport of COPI vesicles between the
ER and the Golgi. Genetic analyses have shown that Rab2,
along with a network of effectors, GAPs and interacting
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proteins, is required for proper sorting of soluble and trans-
membrane LDCV components (79,80,81,82,83). A pair of
DIMM targets, REP (Rab escort protein) and l(1)G0144,
indicate the importance of Rab prenylation for DIMM
functions (84). Thus DIMM, normally orchestrates vesicu-
lar trafficking (17), probably in part on the basis of its abil-
ity to coordinate expression of the Rab 2 protein and as well
two critical components shown to regulate Rab activity. Fi-
nally,Ykt-6 is an intriguingDIMMtarget: we first identified
it in an embryonic screen forDIMMupregulated genes (21).
Mammalian Ykt-6 is a prenylated ER-Golgi SNARE, en-
riched in neurons and partially overlapping with lysosomes
and dense-core secretory granules (85,86).
Cell metabolism. DIMM neuronal cell bodies are large
compared to their non-NE neuronal cohorts and they syn-
thesize large amounts of secretory proteins, by definition. In
this regard, Luo et al. (87) and Gu et al. (88) have recently
shown that Insulin Receptor signaling controls DIMM-
expressing neuron size; Luo et al. (87) find that it does so in
a dimm-dependent manner and furthermore, that DIMM
controls InR levels in vivo. Our results suggest that DIMM
regulation of InR is direct and that it includes coordinate
regulation of at least one potential substrate, rhea.
A separate class of DIMM targets highlights the role of
RNA metabolism in supporting a dedicated pro-secretory
phenotype. In particular, polyA BP, pasilla (ps) and alan
shepherd (shep) all areRNAbinding proteins with potential
broad-scale regulation of the translational capacity of NE
cells. Control of specific RNA binding proteins could be a
mechanism by which dimm regulates neuropeptide mRNA
stability. The ps gene has previously been implicated in pro-
secretory functions in salivary glands, wherein the loss of
function phenotype includes a defect of apical secretion
(89).
A common gene targeted by DIMM andMist1. Finally, we
observe that a single gene is held in common on current lists
of gene targets between DIMM and its closest mammalian
ortholog, Mist1 (62). Genetic analyses of the two factors
suggest they have similar roles supporting secretory activ-
ity in serous exocrine cells (Mist1) and in NE cells (DIMM)
(14). Tian et al. (62) identified 10 Mist1 target genes, and
of these, one of the 10, FNDC3A, is also found in the set
of high-confidence DIMM targets, defined in the present
work (CG42389). This gene encodes a membrane spanning
protein with multiple fibronectin domains and is related to
signaling proteins like sidekick, DSCAM, and the tyrosine
phosphatase DLAR.
Direct versus indirect DIMM regulation of the NE phenotype
DIMM exhibits the remarkable property of conferring syn-
thesis and accumulation of functional LDCV onto neurons
in vivo that do not normally display LDCV (17). How it
achieves this complex cellular performance at a molecular
level motivates our efforts. To that end, we compiled a list
of 212 targets using genome-wide methods and the analy-
sis, as discussed above, revealedmany genes long-associated
with NE function and LDCV biology. However, there are
notably several critical ‘NE-related’ genes that are not in-
cluded in the list of DIMM targets. These are genes whose
expression patterns are essentially equal to or overlap with
that of DIMM (e.g. PICK1––(49,90); nemy––(91); synapto-
tagmins α and β––(92)). It is possible that some of these are
in fact direct DIMM targets and thus represent false nega-
tives in our study.However there is experimental evidence to
suggest that, at least for some critical NE proteins, DIMM
regulation is substantial, but indirect (93).
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